Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
2.960
+0.030 (1.02%)
At close: May 13, 2025, 4:00 PM
3.190
+0.230 (7.77%)
Pre-market: May 14, 2025, 7:27 AM EDT
Absci Revenue
Absci had revenue of $1.18M in the quarter ending March 31, 2025, with 31.29% growth. This brings the company's revenue in the last twelve months to $4.82M, down -9.95% year-over-year. In the year 2024, Absci had annual revenue of $4.53M, down -20.71%.
Revenue (ttm)
$4.82M
Revenue Growth
-9.95%
P/S Ratio
71.62
Revenue / Employee
$30,669
Employees
157
Market Cap
377.54M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ABSI News
- 8 hours ago - Absci Corporation (ABSI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 15 hours ago - Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results - GlobeNewsWire
- 15 hours ago - Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease - GlobeNewsWire
- 4 weeks ago - Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025 - GlobeNewsWire
- 5 weeks ago - Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market - Seeking Alpha
- 6 weeks ago - Absci to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 2 months ago - Absci Corporation (ABSI) Q4 2024 Earnings Call Transcript - Seeking Alpha